Avacta Group News and Activities

View the org chart displaying its 13 main executives

Most searched biographies at Avacta Group

• Christina Coughlin, Chief Executive Officer and Director
• Richard Hughes, Non-Executive Chairman of the Board
• Paul Fry, Non-Executive Director

Popular executive movements at Avacta Group

• Patrick Vink has joined the company as Deputy Chairman of the Board  (posted on July 8 2026).
• Karen Harrison, Chief Operating Officer, has left the company  (posted on July 8 2026).
• Richard Hughes who is Director, will become Non-Executive Chairman of the Board on Jun. 22, 2026  (posted on May 30 2026).

Click here to view some more movements at Avacta Group

Create your alert
to follow the executive moves at Avacta Group.

Avacta Group has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Avacta Group

• Location | Avacta Life Sciences Limited
• Location | Avacta Life Sciences Limited
• Website Disclaimer | Avacta Life Sciences Limited
• LG Chem renews license triggering payment to Avacta | Avacta Life Sciences Limited
• Re: Press Speculation | Avacta Life Sciences Limited

Social media about Avacta Group

• Avacta Group on Wikipedia, Google News & Yahoo Finance
• Avacta Group on LinkedIn, X (Twitter) & YouTube